Similarly, for the TGFBR2 rs3773651 SNP, an increased risk of MetS was observed among the subjects after adjustment for covariates for genetic models, including the dominant model (OR = 1.59; 95% CI = 1.28–1.98; P = 3.1 × 10−5). This evidence concerns the gene TGFBR2 and metabolic syndrome.